DNA methylation of sarcosine dehydrogenase (SARDH) loci as a prognosticator for renal cell carcinoma

  • Authors:
    • Mehrdad Mazdak
    • Hossein Tezval
    • Janne Carmen Callauch
    • Natalia Dubrowinskaja
    • Inga Peters
    • Carsten Bokemeyer
    • Jörg Hennenlotter
    • Arnulf Stenzl
    • Markus A. Kuczyk
    • Jürgen Serth
  • View Affiliations

  • Published online on: September 9, 2019     https://doi.org/10.3892/or.2019.7305
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

DNA methylation plays an important role in the genesis and progression of tumor diseases. To identify new DNA methylation markers possibly associated with the clinical characteristics of renal cell carcinoma (RCC), we investigated loci in the sarcosine dehydrogenase (SARDH) gene. SARDH is involved in the metabolism of the glycine‑derivative sarcosine and is closely linked through a functional control loop. Statistical evaluation of methylation data and clinical characteristics of patients showed that kidney tumors with clinically aggressive features such as a high tumor stage, positive lymph nodes, distant metastases or a previously advanced tumor status exhibited significantly lower methylation of a locus in the SARDH gene. Moreover, SARDH methylation was found to be a significant prognostic factor for recurrence‑free survival in RCC patients showing statistical independence from the clinical prognosticators, grade, stage and state of metastasis. In conclusion, the methylation status of the SARDH‑CGI was identified as an independent prognostic candidate marker for RCC.

Related Articles

Journal Cover

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Mazdak, M., Tezval, H., Callauch, J.C., Dubrowinskaja, N., Peters, I., Bokemeyer, C. ... Serth, J. (1899). DNA methylation of sarcosine dehydrogenase (SARDH) loci as a prognosticator for renal cell carcinoma. Oncology Reports, 0, 0-0. https://doi.org/10.3892/or.2019.7305
MLA
Mazdak, M., Tezval, H., Callauch, J. C., Dubrowinskaja, N., Peters, I., Bokemeyer, C., Hennenlotter, J., Stenzl, A., Kuczyk, M. A., Serth, J."DNA methylation of sarcosine dehydrogenase (SARDH) loci as a prognosticator for renal cell carcinoma". Oncology Reports 0.0 (1899): 0-0.
Chicago
Mazdak, M., Tezval, H., Callauch, J. C., Dubrowinskaja, N., Peters, I., Bokemeyer, C., Hennenlotter, J., Stenzl, A., Kuczyk, M. A., Serth, J."DNA methylation of sarcosine dehydrogenase (SARDH) loci as a prognosticator for renal cell carcinoma". Oncology Reports 0, no. 0 (1899): 0-0. https://doi.org/10.3892/or.2019.7305